Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
SPRINT-MS: A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis (NN 102)
Grant
Overview
Affiliation
Overview
Awarded By
MASSACHUSETTS GENERAL HOSPITAL
Total Award Amount
9460.00
Direct Costs
6435.00
Sponsor Award Id
Affiliation
Contributor
John Rinker II
Investigator
Khurram Bashir
Principal Investigator
Louis Nabors M.D.
Investigator
Michael Vaphiades
Investigator
William Meador
Investigator